Skip to content

Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far

In This Article

  • On March 26, 2020, the Department of Medicine held its third virtual Grand Rounds presentation related to COVID-19
  • Benjamin Medoff, MD, chief of Pulmonary and Critical Care at Massachusetts General Hospital, along with other members of the Greater Boston medical community, presented on respiratory failure in COVID-19, including management, treatment in clinical trials and the need for biomarkers

On March 19, 2020, the Department of Medicine held its second virtual Grand Rounds presentation related to COVID-19. Benjamin Medoff, MD, chief of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, along with other members of the Greater Boston medical community, presented on respiratory failure in COVID-19, including management, treatment in clinical trials and the need for biomarkers.

The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Massachusetts General Hospital, and speakers included Jehan Alladina, MD, Division of Pulmonary and Critical Care at Mass General, Rebecca Baron, MD, Division of Pulmonary and Critical Care at Brigham and Women's Hospital, Ari Moskowitz, MD, MICU at Beth Isreal Deaconess Medical Center, Jayaraj Rajagopal, MD, Center of Regenerative Medicine at Mass General, Jason Griffith, MD, PhD, Division of Pulmonary and Critical Care at Mass General, Robert Hallowell, MD, Pulmonary Clinic at Beth Israel Deaconess Medical Center, and Taylor Thompson, MD, Division of Pulmonary and Critical Care at Mass General.

Watch the Grand Rounds Presentation »

View all COVID-19 Updates

Learn about COVID-19 Grand Rounds at Mass General

Related topics

Related

The hospital announces that the Infectious Disease Division has started enrolling patients in an international study of the antiviral drug, Remdesivir, which aims to treat those with the novel coronavirus (COVID-19).

Related

David Louis, MD, pathologist-in-chief at Massachusetts General Hospital, explains how COVID-19 assays are being rapidly developed and what Mass General is doing to alleviate the scarcity of tests.